Skip to main content
. 2021 Dec 17;64(1):e14957. doi: 10.1111/ped.14957

Table 4.

RSV incidence in the JMDC population per 1000 by age group and setting of care for 2017 to 2018

Age (months) 0–2 3–5 6–11 12–23 0–5 0–11 0–23
All No. of RSV infections 1,845 3,052 4,489 3,160 4,897 9,386 12 546
Total PY 29 121 28 099 45 016 44 947 57 220 102 236 147 183
Incidence per 1,000 PY (95% CI) 63.4 (60.5–66.3) 109.0 (104.8–112.5) 100.0 (96.8–102.6) 70.0 (67.9–72.8) 85.6 (83.2–88.0) 91.8 (90.0–93.7) 85.2 (83.8–86.7)
Outpatients No. of RSV infections 1,543 2,941 4,376 3,010 4,484 8,860 11 870
Total PY 29 143 28 186 45 211 45 265 57 329 102 540 147 805
Incidence per 1,000 PY (95% CI) 52.9 (50.3–55.6) 104.3 (100.6–108.1) 96.8 (93.9–99.7) 66.5 (64.1–68.9) 78.2 (75.9–80.5) 86.4 (84.6–88.2) 80.3 (78.9–81.8)
Inpatients§ No. of RSV infections 1,087 953 850 693 2,040 2,890 3,583
Total PY 29 146 28 446 47 049 49 533 57 592 104 641 154 174
Incidence per 1,000 PY (95% CI) 37.3 (35.1–39.5) 33.5 (31.4–35.6) 18.1 (16.9–19.3) 14.0 (13.0–15.0) 35.4 (33.9–37.0) 27.6 (26.6–28.6) 23.2 (22.5–24.0)

All: patients with outpatient visit only or hospitalization.

Outpatient: patients with any outpatient visits – i.e. outpatient visits only and outpatients who were subsequently hospitalized.

§Inpatients: patients with any hospitalization – i.e. hospitalization only and outpatients after hospitalization.

CI: confidence interval; JMDC: Japan Medical Data Center; PY: person‐years; RSV: respiratory syncytial virus.